Synthace

Synthace

Synthace is a software company based out of London, UK building automation software that gives biologists the ability to control and analyze the performance of lab hardware.

All edits

Edits on 29 April, 2020
Nico Faraguna
Nico Faraguna edited on 29 April, 2020 8:55 pm
Edits made to:
Infobox (--1 properties)

Infobox

B2X
Edits on 31 January, 2020
Dawson Sewell"Approved suggestion #716867"
Dawson Sewell edited on 31 January, 2020 8:24 pm
Edits made to:
Infobox (+2 properties)
Edits on 28 January, 2020
Dawson Sewell"Approved suggestion #716880"
Dawson Sewell edited on 28 January, 2020 10:29 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 22 January, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 22 January, 2020 8:24 am
Edits made to:
Article (+11/-11 characters)

Article

On December 14th, 2014 Synthace announced that it raised $3,500,000 in seed funding from Sofinnova Partners, SOSventuresSOSventures, Bioeconomy Capital, and the Rainbow Seed Fund.

Edits on 21 January, 2020
Golden AI
Golden AI edited on 21 January, 2020 4:53 pm
Edits made to:
Infobox (+1 properties)

Infobox

Investors
Edits on 13 November, 2019
Peter Crane
Peter Crane edited on 13 November, 2019 9:37 pm
Edits made to:
Article (+30/-35 characters)

Article

Antha is an open source language anda cloud based operating platform made by Synthace. Antha is made to help scientists design, execute, analyze, and replicate aspects of their lab work. The company claims that Antha can produce a 100-fold improvement in lab productivity, a 50% reduction in the time it takes to generate internal vector constructions, a 33% reduction in the cost of running experiments, and increase enzymatic activity by 100X compared to pre-Antha platforms. Below you can find brief descriptions of specific services Antha software offers to users which are: construct assembly, data integration, and liquid handling.

...

Synthace completed its series A funding round on SeptmberSeptember 19th, 2017. They received $9,600,000 in funding from White Cloud Capital (Luminous Ventures), Sofinnova Partners, SOSventures, Bioeconomy Capital, Amadeus Capital, and 11.2 Capital.

Edits on 28 October, 2019
Golden AI"IBI-85"
Golden AI edited on 28 October, 2019 9:47 pm
Edits made to:
Infobox (+1 properties)
Edits on 18 September, 2019
Julius John Villarisco
Julius John Villarisco approved a suggestion from Golden's AI on 18 September, 2019 11:55 pm
Edits made to:
Article (+4/-4 characters)

Article

Oxford Biomedica is the lead partner in this partnership between Synthace, CellCell and Gene Therapy Catapult, and Stratophase. The partnerships between these companies was announced in August, 2017 and is focused on developing more efficient cell and gene manufacturing systems and technologies.

Golden AI
Golden AI edited on 18 September, 2019 11:08 am
Edits made to:
Infobox (+1 properties)
Edits on 9 August, 2019
Golden AI
Golden AI edited on 9 August, 2019 11:54 pm
Edits made to:
Infobox (+1 properties)
Edits on 8 August, 2019
Thomas Shaddox
Thomas Shaddox edited on 8 August, 2019 5:47 pm
Edits made to:
Infobox (+1 properties)

Infobox

Location
Edits on 12 June, 2019
Golden AI
Golden AI edited on 12 June, 2019 10:46 pm
Edits made to:
Infobox (+1 properties)

Infobox

Funding rounds
Edits on 30 May, 2019
Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019 2:25 am
Edits made to:
Article (+16/-16 characters)

Article

Synthace is a software company, founded in 2011 by Sean Ward, Markus GershaterMarkus Gershater, and Christopher Grant. Synthace builds software tools that work with scientists and their lab hardware with the goal of improving lab productivity. Their software allows scientists to communicate with their lab hardware in a way that lets them plan, execute, and repeat biological experiments.

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019 2:20 am
Edits made to:
Article (+18/-18 characters)

Article

Synthace raised $2,000,000 in seed funding on September 24th, 2013. Investors include Sofinnova PartnersSofinnova Partners, Innovative UK, and Keith Willey.

Will Suter
Will Suter approved a suggestion from Golden's AI on 30 May, 2019 2:16 am
Edits made to:
Article (+9/-9 characters)

Article

Synthace is a software company, founded in 2011 by Sean WardSean Ward, Markus Gershater, and Christopher Grant. Synthace builds software tools that work with scientists and their lab hardware with the goal of improving lab productivity. Their software allows scientists to communicate with their lab hardware in a way that lets them plan, execute, and repeat biological experiments.

Golden AI
Golden AI edited on 29 May, 2019 12:41 pm
Edits made to:
Infobox (+1 properties)

Infobox

Golden AI
Golden AI edited on 29 May, 2019 12:26 pm
Edits made to:
Infobox (+1 properties)

Infobox

Founder
Edits on 7 March, 2019
Golden AI
Golden AI edited on 7 March, 2019 10:36 pm
Edits made to:
Infobox (+1 properties)
Sameeha Sulaiman
Sameeha Sulaiman edited on 7 March, 2019 12:55 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 28 January, 2019
Golden AI"Import data"
Golden AI edited on 28 January, 2019 11:13 pm
Edits made to:
People (+26 rows) (+52 cells) (+586 characters)

People

Name
Role
Related Golden topics

Alberto Morabito

Employee

Aleksandr Mattal

Employee

Alessandra Sollberger

Investor

Charles Bird

Employee

Charlotte Ward

Employee

Cosmina Busaga

Employee

Craig Gershater

Advisor

David Jones

Advisor

David Lucas

Investor

Donald Nguyen

Employee

Howard Palmer

Attorney

Johan Schuijt-Li

Employee

John Anthony Knight

Investor

John Ward

Advisor

Josephine Livingston

Employee

Keith Willey

Investor

Lauren Fovargue

Employee

Martin Gallagher

Employee

Max Bertfield

Employee

Max Rothier Bautzer

Employee

Michail Eleftheriou

Investor

Milan Limbu

Employee

Rob Carlson

Investor

Sami Mikati

Board member

Sandie Dobbie

Board member

Page 1 of 2

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.